Total samples analysed | 23 478 | 25 727 | 28 313 | 33 445 | 32 526 | 30 398 | 28 587 | 28 008 | 230 482 |
Positive cases total | 76 (0.32%) | 89 (0.35%) | 103 (0.36%) | 82 (0.36%) | 72 (0.22%) | 105 (0.35%) | 119 (0.42%) | 106 (0.38%) | 752 (0.33%) |
Cannabinoids | 36 (0.15%) | 52 (0.2%) | 38 (0.13%) | 40 (0.12%) | 30 (0.1%) | 42 (0.14%) | 40 (0.14%) | 40 (0.14%) | 318 (0.14%) |
Anabolic steroids and hormones | 11 (0.05%) | 10 (0.04%) | 15 (0.05%) | 9 (0.03%) | 5 (0.02%) | 14 (0.05%) | 18 (0.06%) | 11 (0.04%) | 93 (0.04%) |
Others (eg, cocaine, stimulants, diuretics) | 29 (1.12%) | 27 (0.10%) | 50 (0.18%) | 33 (0.1%) | 37 (0.11%) | 49 (0.16%) | 61 (0.21%) | 55 (0.2%) | 341 (0.15%) |